RU2017104902A - Составы лубрикантов - Google Patents

Составы лубрикантов Download PDF

Info

Publication number
RU2017104902A
RU2017104902A RU2017104902A RU2017104902A RU2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A
Authority
RU
Russia
Prior art keywords
lubricant
amount
paragraphs
lubricant according
present
Prior art date
Application number
RU2017104902A
Other languages
English (en)
Other versions
RU2017104902A3 (ru
RU2747029C2 (ru
Inventor
Курт РИЧАРДС
Эндрю ГУВЕР
Original Assignee
Реоксин Дискаверис Груп, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Реоксин Дискаверис Груп, Инк. filed Critical Реоксин Дискаверис Груп, Инк.
Publication of RU2017104902A publication Critical patent/RU2017104902A/ru
Publication of RU2017104902A3 publication Critical patent/RU2017104902A3/ru
Application granted granted Critical
Publication of RU2747029C2 publication Critical patent/RU2747029C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M129/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen
    • C10M129/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen having a carbon chain of less than 30 atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/028—Other inorganic materials not covered by A61L31/022 - A61L31/026
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/10—Materials for lubricating medical devices
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2229/00—Organic macromolecular compounds containing atoms of elements not provided for in groups C10M2205/00, C10M2209/00, C10M2213/00, C10M2217/00, C10M2221/00 or C10M2225/00 as ingredients in lubricant compositions
    • C10M2229/02—Unspecified siloxanes; Silicones
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
    • C10N2030/04—Detergent property or dispersant property
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
    • C10N2030/16—Antiseptic; (micro) biocidal or bactericidal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Claims (23)

1. Лубрикант, содержащий гипохлорит; эмульгатор; и силиконовый полимер.
2. Лубрикант по п. 1, дополнительно содержащий буфер.
3. Лубрикант по п. 2, отличающийся тем, что буфер представляет собой фосфат натрия.
4. Лубрикант по любому из пп. 2-3, отличающийся тем, что буфер присутствует в количестве примерно 0,05%, 0,1%, 0,2%, 0,3%, 0,4%, 0,5%, 1%, 1,5%, 2%, 2,5%, 3%, 3,5%, 4%, 4,5%, 5%, 6%, 7%, 10% или 15% масс./об.
5. Лубрикант по любому из пп. 2-4, отличающийся тем, что буфер присутствует в количестве примерно 0,2% масс./об.
6. Лубрикант по любому из пп. 1-5, отличающийся тем, что гипохлорит присутствует в количестве от примерно 50 до примерно 100 ppm.
7. Лубрикант по любому из пп. 1-6, отличающийся тем, что гипохлорит присутствует в количестве примерно 75 ppm.
8. Лубрикант по любому из пп. 1-7, отличающийся тем, что эмульгатор представляет собой силикат магния и натрия.
9. Лубрикант по любому из пп. 1-8, отличающийся тем, что эмульгатор присутствует в количестве примерно 0,05%, 0,1%, 0,2%, 0,3%, 0,4%, 0,5%, 1%, 1,5%, 2%, 2,5%, 3%, 3,5%, 4%, 4,5%, 5%, 6%, 7%, 10% или 15% масс./об.
10. Лубрикант по любому из пп. 1-9, отличающийся тем, что эмульгатор присутствует в количестве примерно 3,25% масс./об.
11. Лубрикант по любому из пп. 1-10, отличающийся тем, что силиконовый полимер представляет собой диметикон.
12. Лубрикант по любому из пп. 1-11, отличающийся тем, что силиконовый полимер присутствует в количестве примерно 0,5%, 1%, 5%, 10%, 15%, 20%, 30%, 40% или 50% масс./об.
13. Лубрикант по любому из пп. 1-12, отличающийся тем, что силиконовый полимер присутствует в количестве примерно 10% масс./об.
14. Лубрикант по любому из пп. 1-13, дополнительно содержащий воду.
15. Лубрикант по любому из пп. 1-14, отличающийся тем, что лубрикант обладает значением осмоляльности, составляющим примерно 10, 15, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 65, 70, 80, 90 или 100 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
16. Лубрикант по любому из пп. 1-15, отличающийся тем, что лубрикант обладает значением осмоляльности примерно 22 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
17. Лубрикант по любому из пп. 1-16, отличающийся тем, что лубрикант обладает значением осмоляльности примерно 54 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
18. Лубрикант по п. 2, отличающийся тем, что гипохлорит содержится в количестве примерно 75 ppm, причем эмульгатор содержит силикат магния и натрия в количестве примерно 3,25% масс./об., причем силиконовый полимер содержит диметикон в количестве примерно 10% масс./об., причем буфер содержит фосфат натрия в количестве примерно 0,2% масс./об. и причем лубрикант дополнительно содержит воду в количестве примерно 61,55% масс./об.
19. Лубрикант, содержащий гипохлорит; силикат магния и натрия; диметикон; и фосфат натрия.
20. Лубрикант по п. 19, отличающийся тем, что гипохлорит присутствует в количестве примерно 75 ppm, силикат магния и натрия присутствует в количестве примерно 3,25% масс./об., диметикон присутствует в количестве примерно 10% масс./об., фосфат натрия присутствует в количестве примерно 0,2% масс./об. и при этом лубрикант дополнительно содержит воду в количестве примерно 61,55% масс./об.
21. Применение лубриканта по любому из пп. 1-20 для повышения комфорта или смазывающего действия.
22. Способ применения лубриканта, включающий обеспечение лубриканта по любому из пп. 1-20 и нанесение лубриканта.
23. Способ получения лубриканта по любому из пп. 1-20, включающий обеспечение раствора гипохлорита и силиконового полимера и смешивание указанных ингредиентов с получением лубриканта.
RU2017104902A 2016-05-18 2017-02-15 Составы лубрикантов RU2747029C2 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15/158442 2016-05-18
US15/158,442 US9474768B1 (en) 2016-05-18 2016-05-18 Lubricant formulations
US15/266147 2016-09-15
US15/266,147 US9833406B1 (en) 2016-05-18 2016-09-15 Lubricant formulations
PCT/US2016/056760 WO2017200565A1 (en) 2016-05-18 2016-10-13 Lubricant formulations
USPCT/US2016/056760 2016-10-13

Publications (3)

Publication Number Publication Date
RU2017104902A true RU2017104902A (ru) 2018-08-15
RU2017104902A3 RU2017104902A3 (ru) 2020-03-24
RU2747029C2 RU2747029C2 (ru) 2021-04-23

Family

ID=57136571

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017104902A RU2747029C2 (ru) 2016-05-18 2017-02-15 Составы лубрикантов

Country Status (14)

Country Link
US (4) US9474768B1 (ru)
EP (1) EP3246015B1 (ru)
JP (2) JP6464406B2 (ru)
KR (1) KR102649938B1 (ru)
CN (2) CN115569241A (ru)
AP (1) AP2017009767A0 (ru)
AU (1) AU2016253593B2 (ru)
CA (1) CA2958011C (ru)
MX (1) MX369169B (ru)
NZ (2) NZ725569A (ru)
RU (1) RU2747029C2 (ru)
TW (2) TWI674099B (ru)
WO (1) WO2017200565A1 (ru)
ZA (1) ZA201607310B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2835620C1 (ru) * 2019-09-12 2025-03-03 Интервет Интернэшнл Б.В. Комбинированная вакцина для внутрикожного введения

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
WO2017127452A1 (en) 2016-01-19 2017-07-27 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
US9833471B1 (en) 2016-09-15 2017-12-05 Reoxcyn Discoveries Group, Inc. Hypochlorous acid-based hand sanitizer
US20180200165A1 (en) 2017-01-16 2018-07-19 Reoxcyn Innovation Group, Llc Dentifrice formulations and methods of oral care
EP3645017A4 (en) 2017-06-28 2021-05-19 Collidion, Inc. COMPOSITIONS, PROCEDURES AND USES FOR CLEANING UP, DISINFECTING AND / OR STERILIZATION
WO2019070920A1 (en) * 2017-10-03 2019-04-11 Collidion, Inc. COMPOSITIONS, METHODS AND USES FOR ENHANCING A ZONE OF SKIN OR HAIR
US10292911B1 (en) * 2017-12-22 2019-05-21 Reoxcyn, Llc Stable redox compositions and methods of use
JP6584588B2 (ja) * 2017-12-22 2019-10-02 レオキシン・エルエルシー セルライトの治療のための組成物及び方法
US10828325B2 (en) * 2017-12-22 2020-11-10 Reoxcyn, Llc Hypochlorite compositions for the treatment of traumatic brain injury
JP7379342B2 (ja) 2018-01-14 2023-11-14 コリディオン，インコーポレイテッド 洗浄、消毒、滅菌、および／または処置のための組成物、キット、方法、および使用
US10918663B2 (en) * 2018-04-03 2021-02-16 Reoxcyn, Llc Compositions and methods for the treatment of bacterial vaginosis
US11602582B2 (en) * 2018-04-10 2023-03-14 Chemsil Silicones, Inc. Intimate care lubricant compositions and methods for making same
EP4102968A4 (en) 2020-02-14 2024-04-10 Collidion, Inc. COMPOSITIONS, KITS, METHODS AND USES FOR CLEANING, DISINFECTING, STERILIZING AND/OR TREATING

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1200165A (en) 1913-10-30 1916-10-03 Charles F Burgess Method and apparatus for sterilizing.
JPS5541210B2 (ru) * 1974-01-29 1980-10-22
US4316787A (en) 1979-08-06 1982-02-23 Themy Constantinos D High voltage electrolytic cell
US4236992A (en) 1979-08-06 1980-12-02 Themy Constantinos D High voltage electrolytic cell
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
US4983779A (en) * 1986-07-17 1991-01-08 The Board Of Governors Of Wayne State University Process for the preparation of vinyl ethers
JPS6456188A (en) 1987-03-11 1989-03-03 Tatsuo Okazaki Electrolyzer for water
GB8807752D0 (en) 1988-03-31 1988-05-05 Unilever Plc Bleaching composition
US4956184A (en) 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5334383A (en) 1990-05-23 1994-08-02 Medical Discoveries, Inc. Electrically hydrolyzed salines as in vivo microbicides for treatment of cardiomyopathy and multiple sclerosis
US5622848A (en) 1990-05-23 1997-04-22 Medical Discoveries, Inc. Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood
ES2152957T3 (es) * 1993-05-13 2001-02-16 American Cyanamid Co Composiciones acuosas de silicona para revestimiento, metodo para revestir sustratos con las mismas y agujas quirurgicas revestidas producidas de ese modo.
US6117285A (en) 1994-08-26 2000-09-12 Medical Discoveries, Inc. System for carrying out sterilization of equipment
US5507932A (en) 1994-08-26 1996-04-16 Schlumberger Technology Corporation Apparatus for electrolyzing fluids
FR2740777B1 (fr) * 1995-11-02 1998-01-02 Hutchinson Films d'elastomere contenant au moins une substance chimique active, leur procede de preparation et leurs applications
US5712229A (en) * 1995-12-07 1998-01-27 Becton Dickinson And Company Waterborne lubricant for teflon products
CA2317067A1 (en) 1998-01-06 1999-07-15 The Procter & Gamble Company Antimicrobial peroxy acid oral care compositions and methods
US6114398A (en) 1998-03-03 2000-09-05 Ratcliff; Perry A. Personal lubricant to prevent and stop itching
GB2355190B (en) 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US6589568B2 (en) 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
SE0103766D0 (sv) 2001-11-09 2001-11-09 Astrazeneca Ab Novel assay
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050089537A1 (en) 2003-10-27 2005-04-28 Birnholz Jason C. Personal lubricant with silicone polymers
GB0328124D0 (en) 2003-12-04 2004-01-07 Daly James Membrane electrolyser with a two part end design
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20080003171A1 (en) 2004-04-20 2008-01-03 Smith William L Microbial Control Using Hypochlorous Acid Vapor
CN101010261B (zh) 2004-10-08 2010-04-07 日本科技股份有限公司 中性电解水、中性电解水的制造方法及中性电解水的制造装置
EP1829449A4 (en) 2004-11-24 2008-10-08 Maruishi Pharma STERILIZATION COMPOSITION BASED ON LOW-CHLORINOUS ACID
GB0504547D0 (en) 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
WO2006102680A2 (en) 2005-03-23 2006-09-28 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
US20060241002A1 (en) 2005-04-26 2006-10-26 Rogozinski Wallace J Sodium hypochlorite gel composition
US8083586B2 (en) 2005-06-22 2011-12-27 Nokia Corporation System and method for providing interoperability of independently-operable electronic games
US20070172412A1 (en) 2006-01-26 2007-07-26 Linda Hratko Thickened fluid composition comprising chlorine dioxide
EP1986952A4 (en) 2006-02-22 2011-03-30 Puricore Inc METHOD FOR THE TREATMENT OF MUCOVISCIDOSIS
US8673297B2 (en) 2006-02-28 2014-03-18 Basf Corporation Chlorine dioxide based cleaner/sanitizer
US20070281008A1 (en) 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
EP1886664A1 (en) 2006-08-08 2008-02-13 José Sidnei Pereira N-chloroamines containing compositions
WO2008089268A2 (en) 2007-01-16 2008-07-24 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
JP6099294B2 (ja) 2007-03-13 2017-03-22 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 一酸化二塩素を含む抗菌溶液ならびにその製造方法および使用方法
GB0713799D0 (en) 2007-07-17 2007-08-22 Byotrol Llc Anti-microbial compositions
US20090068122A1 (en) 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
US8770201B2 (en) * 2007-10-26 2014-07-08 Glycobiosciences Inc. Condom with multifunctional coating
US20090148342A1 (en) 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US9446072B2 (en) 2007-10-30 2016-09-20 Reoxcyn Discoveries Group, Inc. Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity
US20140044800A1 (en) 2007-10-30 2014-02-13 Daniel Robinson Stable Reactive Oxygen Composition
US8945630B2 (en) 2008-04-11 2015-02-03 Aquilabs S.A. Method of producing and applications of composition of hypochlorous acid
WO2010004699A1 (ja) 2008-07-09 2010-01-14 野口歯科医学研究所株式会社 口臭抑制剤及びその生成方法
WO2010009131A2 (en) 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth polishing compositions and methods of tooth polishing without mechanical abrasion
US20100078331A1 (en) 2008-10-01 2010-04-01 Scherson Daniel A ELECTROLYTIC DEVICE FOR GENERATION OF pH-CONTROLLED HYPOHALOUS ACID AQUEOUS SOLUTIONS FOR DISINFECTANT APPLICATIONS
US20100012132A1 (en) 2008-11-12 2010-01-21 Chemsil Silicones, Inc. Clear, washable lubricant compositions, and methods of making same
AU2009333186A1 (en) 2008-12-17 2011-07-07 Tennant Company Method and apparatus for applying electrical charge through a liquid to enhance sanitizing properties
US8303962B2 (en) 2009-01-06 2012-11-06 C3 Jian, Inc. Antibacterial and antifungal peptides
EP2411021A4 (en) 2009-03-23 2012-09-05 Kross Link Lab METHOD FOR SUPPRESSION OR PREVENTION OF FIBROUS ADHESION FORMATION USING MULTI-COMPONENT AQUEOUS OXYCHLORIN COMPOSITION PREPARED ON SITE
BR112012006891A2 (pt) 2009-07-30 2019-09-24 Oculus Innovative Sciences Inc formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo
US20110052506A1 (en) 2009-08-31 2011-03-03 Collegium Pharmaceutical, Inc. Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
US20110065798A1 (en) * 2009-09-17 2011-03-17 Becton, Dickinson And Company Anti-infective lubricant for medical devices and methods for preparing the same
US20120046556A1 (en) * 2010-04-09 2012-02-23 Block Robert M Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms
CA2807336A1 (en) 2010-08-05 2012-02-09 Biofilm Ip, Llc Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
US20120148516A1 (en) 2010-12-10 2012-06-14 Precision Dermatology, Inc. Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
CN102167997B (zh) 2011-03-11 2013-06-12 刘小清 一种不需防腐剂的天然消毒洗涤组合物
JP6355926B2 (ja) 2011-03-18 2018-07-11 レルム セラピューティクス，インコーポレイテッド 安定化次亜ハロゲン酸溶液
US20130164228A1 (en) 2011-12-21 2013-06-27 Colgate-Palmolive Company Compositions comprising gallates and gallamides
ES2861300T3 (es) 2012-02-20 2021-10-06 Basf Se Potenciación de la actividad antimicrobiana de biocidas con polímeros
US20150246131A1 (en) 2012-10-04 2015-09-03 Church & Dwight, Co., Inc. Water-based personal lubricants with a silicone component
US9949916B2 (en) 2012-10-04 2018-04-24 Church & Dwight Co., Inc. Non-irritating lubricant compositions with active sensorial agents
WO2015002932A1 (en) 2013-07-01 2015-01-08 Puricoe, Inc. Antimicrobial compositions comprising hypochlorous acid and silver
JP2015016408A (ja) 2013-07-10 2015-01-29 モレックス インコーポレイテドＭｏｌｅｘ Ｉｎｃｏｒｐｏｒａｔｅｄ 酸性電解水およびその製造方法、ならびに該酸性電解水を含む洗浄剤および殺菌剤
WO2015035416A2 (en) 2013-09-09 2015-03-12 Reoxcyn Discoveries Group, Inc. Method of increasing energy expenditure
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
WO2015061753A1 (en) 2013-10-24 2015-04-30 Reoxcyn Discoveries Group, Inc. Redox signaling gel formulation
US20150125543A1 (en) 2013-11-07 2015-05-07 Simple Science Limited Gel disinfecting composition
CN104922055A (zh) * 2014-03-19 2015-09-23 张益寿 用于润滑保湿消毒灭菌的半流体组成物及其使用方法
CN104476966A (zh) * 2014-11-12 2015-04-01 颍上县陈家工艺家具有限公司 基于木质家具镶嵌贝壳拼花的工艺
WO2016100543A2 (en) 2014-12-16 2016-06-23 Puricore, Inc. Hypochlorous acid formulations and methods for treating skin conditions
WO2017127452A1 (en) 2016-01-19 2017-07-27 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US9474768B1 (en) * 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2835620C1 (ru) * 2019-09-12 2025-03-03 Интервет Интернэшнл Б.В. Комбинированная вакцина для внутрикожного введения

Also Published As

Publication number Publication date
ZA201607310B (en) 2020-08-26
CA2958011A1 (en) 2017-11-18
BR102017003973A2 (pt) 2017-12-05
KR102649938B1 (ko) 2024-03-22
NZ725569A (en) 2018-02-23
US9474768B1 (en) 2016-10-25
KR20170130275A (ko) 2017-11-28
US11083689B2 (en) 2021-08-10
AU2016253593B2 (en) 2022-06-02
NZ738113A (en) 2018-07-27
US20180325809A1 (en) 2018-11-15
JP6821639B2 (ja) 2021-01-27
EP3246015A1 (en) 2017-11-22
JP6464406B2 (ja) 2019-02-06
TW201919660A (zh) 2019-06-01
MX2016013744A (es) 2017-11-17
RU2017104902A3 (ru) 2020-03-24
US20170333343A1 (en) 2017-11-23
TWI674099B (zh) 2019-10-11
MX369169B (es) 2019-10-30
WO2017200565A1 (en) 2017-11-23
CA2958011C (en) 2024-05-14
TW201740956A (zh) 2017-12-01
RU2747029C2 (ru) 2021-04-23
US10471003B2 (en) 2019-11-12
JP2017206668A (ja) 2017-11-24
EP3246015B1 (en) 2019-08-14
CN107397757A (zh) 2017-11-28
AU2016253593A1 (en) 2017-12-07
CN115569241A (zh) 2023-01-06
CN107397757A8 (zh) 2018-06-19
JP2019059950A (ja) 2019-04-18
US20200237655A1 (en) 2020-07-30
US9833406B1 (en) 2017-12-05
AP2017009767A0 (en) 2017-02-28
TWI674098B (zh) 2019-10-11

Similar Documents

Publication Publication Date Title
JP2014139241A5 (ru)
RU2020123688A (ru) Композиции средств личной гигиены и способы стабилизации микробиома
JP2019501639A5 (ru)
EA201591302A1 (ru) Некариесогенное желейное кондитерское изделие
EA201591067A1 (ru) Неводные композиции для ухода за полостью рта
MX361514B (es) Composiciones de limpieza para cuidado personal libres de sulfato.
MY194702A (en) Liquid skin cleansing agent composition
MX386117B (es) Composiciones líquidas acuosas.
EA201891485A1 (ru) Композиция зубной пасты
CL2017001860A1 (es) Agente espumante para usar en la preparación de coberturas comestibles y un método para la preparación de dicho agente.
WO2019123261A3 (en) Oral compositions and methods of use
MX2015012784A (es) Composiciones suavizantes de telas.
RU2013146037A (ru) Косметическая композиция в виде эмульсии вода-в-масле
BR112018006343A2 (pt) composição de gordura de safa reduzidos, e, emulsão aerada
IN2014MN00929A (ru)
MX2017007633A (es) Limpiador liquido para la piel.
EA201692149A1 (ru) Композиции для ухода за полостью рта
RU2017133254A (ru) Композиции, содержащие комбинации органических кислот
RU2017129694A (ru) Смазочная композиция
RU2013146038A (ru) Косметическая композиция в виде эмульсии вода-в-масле
JP6612528B2 (ja) 液体洗浄料
FR3027236B1 (fr) Emulsion aqueuse de peroxyde de dialkyle
RU2017134731A (ru) Ионоактивный водный раствор на основе растворенных неорганических солей, предпочтительно предназначенный для ухода за горлом
RU2017142726A (ru) Офтальмическая композиция, содержащая липоевую кислоту и мукомиметический полимер
MX381831B (es) Composiciones lácteas espumantes.

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant